News
GlyTech, Inc. Gives Lecture at the 2018 Joint Study Meeting of the Drug Discovery Consortium and Pharmaceutical Technology Consortium, Ritsumeikan University.
GlyTech, Inc. CEO Hiroaki Asai gave a lecture today at the 2018 Joint Study Meeting of the Drug Discovery Consortium and Pharmaceutical Technology Consortium led by Ritsumeikan University on the theme of Life Science Innovation in Kyoto. Mr. Asai spoke on how biopharmaceuticals can be created via glycoengineering using a chemical approach.
Last updated: